Diamyd Medical
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
Basic Information
- Category: business
- Website: http://www.diamyd.com/Default.aspx
Documented Facts
- Email: top-slider1@2x-v4.jpg (No linked source recorded for this statement.)
Evidence and Sources
- Diamyd Medical — Official Site (official)
- Diamyd Medical on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Diamyd Medical.
- Canonical profile: https://brandsource.ai/brands/diamyd-medical
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/diamyd-medical/json-ld
- Citation profile API: https://brandsource.ai/api/brands/diamyd-medical/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.